Hasmim M - Search Results

1

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges.

Noman MZ, Hasmim M, Lequeux A, Xiao M, Duhem C, Chouaib S, Berchem G, Janji B. Noman MZ, et al. Among authors: hasmim m. Cells. 2019 Sep 14;8(9):1083. doi: 10.3390/cells8091083. Cells. 2019. PMID: 31540045 Free PMC article. Review.

2

The multifaceted role of autophagy in tumor evasion from immune surveillance.

Janji B, Viry E, Moussay E, Paggetti J, Arakelian T, Mgrditchian T, Messai Y, Noman MZ, Van Moer K, Hasmim M, Mami-Chouaib F, Berchem G, Chouaib S. Janji B, et al. Among authors: hasmim m. Oncotarget. 2016 Apr 5;7(14):17591-607. doi: 10.18632/oncotarget.7540. Oncotarget. 2016. PMID: 26910842 Free PMC article. Review.

3

Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints.

Lequeux A, Noman MZ, Xiao M, Sauvage D, Van Moer K, Viry E, Bocci I, Hasmim M, Bosseler M, Berchem G, Janji B. Lequeux A, et al. Among authors: hasmim m. Cancer Lett. 2019 Aug 28;458:13-20. doi: 10.1016/j.canlet.2019.05.021. Epub 2019 May 25. Cancer Lett. 2019. PMID: 31136782 Free article. Review.

4

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy.

Lequeux A, Noman MZ, Xiao M, Van Moer K, Hasmim M, Benoit A, Bosseler M, Viry E, Arakelian T, Berchem G, Chouaib S, Janji B. Lequeux A, et al. Among authors: hasmim m. Oncogene. 2021 Jul;40(28):4725-4735. doi: 10.1038/s41388-021-01846-x. Epub 2021 Jun 21. Oncogene. 2021. PMID: 34155342 Free PMC article.

5

Cytotoxic T cells - stroma interactions.

Noman MZ, Benlalam H, Hasmim M, Chouaib S. Noman MZ, et al. Among authors: hasmim m. Bull Cancer. 2011 Feb;98(2):E19-24. doi: 10.1684/bdc.2010.1295. Bull Cancer. 2011. PMID: 21339092 Review.

6

Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.

Noman MZ, Messai Y, Carré T, Akalay I, Méron M, Janji B, Hasmim M, Chouaib S. Noman MZ, et al. Among authors: hasmim m. Crit Rev Immunol. 2011;31(5):357-77. doi: 10.1615/critrevimmunol.v31.i5.10. Crit Rev Immunol. 2011. PMID: 22142164 Review.

7

Hypoxia promotes tumor growth in linking angiogenesis to immune escape.

Chouaib S, Messai Y, Couve S, Escudier B, Hasmim M, Noman MZ. Chouaib S, et al. Among authors: hasmim m. Front Immunol. 2012 Feb 23;3:21. doi: 10.3389/fimmu.2012.00021. eCollection 2012. Front Immunol. 2012. PMID: 22566905 Free PMC article.

8

EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction.

Akalay I, Janji B, Hasmim M, Noman MZ, Thiery JP, Mami-Chouaib F, Chouaib S. Akalay I, et al. Among authors: hasmim m. Autophagy. 2013 Jul;9(7):1104-6. doi: 10.4161/auto.24728. Epub 2013 Apr 23. Autophagy. 2013. PMID: 23635487 Free PMC article.

9

Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.

Hasmim M, Noman MZ, Messai Y, Bordereaux D, Gros G, Baud V, Chouaib S. Hasmim M, et al. J Immunol. 2013 Dec 15;191(12):5802-6. doi: 10.4049/jimmunol.1302140. Epub 2013 Nov 13. J Immunol. 2013. PMID: 24227785

10

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.

Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S. Noman MZ, et al. Among authors: hasmim m. J Exp Med. 2014 May 5;211(5):781-90. doi: 10.1084/jem.20131916. Epub 2014 Apr 28. J Exp Med. 2014. PMID: 24778419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters